Literature DB >> 8438385

Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses.

C Clayberger1, S C Lyu, P Pouletty, A M Krensky.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8438385

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

Authors:  S Kaveri; T Vassilev; V Hurez; R Lengagne; C Lefranc; S Cot; P Pouletty; D Glotz; M D Kazatchkine
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

Review 2.  Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.

Authors:  S V Kaveri; L Mouthon; M D Kazatchkine
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

3.  RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action.

Authors:  M C Cuturi; F Christoph; J Woo; S Iyer; S Brouard; J M Heslan; P Pignon; J P Soulillou; R Buelow
Journal:  Mol Med       Date:  1999-12       Impact factor: 6.354

Review 4.  Prevention of transplant rejection: current treatment guidelines and future developments.

Authors:  N Perico; G Remuzzi
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

5.  HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family.

Authors:  E Nossner; J E Goldberg; C Naftzger; S C Lyu; C Clayberger; A M Krensky
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.